HIV associated nephropathy medical therapy: Difference between revisions

	HIV associated nephropathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating HIV associated nephropathy from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
KUB X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
HIV associated nephropathy medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of HIV associated nephropathy medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on HIV associated nephropathy medical therapy
CDC on HIV associated nephropathy medical therapy
HIV associated nephropathy medical therapy in the news
Blogs on HIV associated nephropathy medical therapy
Directions to Hospitals Treating HIV associated nephropathy
Risk calculators and risk factors for HIV associated nephropathy medical therapy

Revision as of 17:02, 13 January 2017

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2];Associate Editor(s)-in-Chief: Krzysztof Wierzbicki M.D. [3]

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{HIV associated nephropathy}}
-{{CMG}}
+{{CMG}}{{APM}};{{AE}}{{KW}}
 ==Overview==
 ==Medical Therapy==
-There is as yet inadeqaute data from randomised controlled trials.
-Treatment with [[HAART]] and [[ACE inhibitors]]/[[Angiotensin receptor blockers]] has been shown to be beneficial and should be given to all patients unless otherwise contra-indicated.  General renoprotective measures and the treatment of the complications of nephrotic syndrome and renal failure are adjunctive.
-[[Corticosteroid]] treatment can be useful in patients who do not respond to the above treatment.  There is some evidence that [[cyclophosphamide]] might be helpful in selective cases, however further trials are required on both steroids and [[cyclophosphamide]] before these drugs can become standardised treatmen if at all.
 ==References==
 {{reflist|2}}